Xenon Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Avoro Capital Advisors LLC Has $261 01 Million Stake in Xenon Pharmaceuticals Inc (NASDAQ:XENE)

Avoro Capital Advisors LLC grew its holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 15.6% during the 4th quarter, HoldingsChannel reports. The firm owned 5,666,666 shares of the biopharmaceutical company’s stock after acquiring an additional 766,666 shares during the quarter. Xenon Pharmaceuticals comprises about 3.6% of Avoro Capital Advisors LLC’s investment portfolio, making […]

News ratings for xenon pharmaceuticals dailyAdvisors asset management incAvoro capital advisorsXenon pharmaceuticals incXenon pharmaceuticals profileCantor fitzgeraldXenon pharmaceuticalsTower research capitalRoyal bankQuarter for xenon pharmaceuticalsNeedham companyBarclays plcXenon pharmaceuticals stockFree reportCapital advisorsResearch capital

Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

05.06.2024 - VANCOUVER, British Columbia, June 05, 2024 (GLOBE NEWSWIRE) - Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced that the company will present at the Goldman Sachs 45th Annual Global .

Ian mortimerJodi regtsXenon corporate affairsXenon pharmaceuticals nasdaqXenon pharmaceuticals incEastern timeChief executiveVon seggernChief commercial officerXenon pharmaceuticals

Xenon Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:XENE)

Xenon Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:XENE)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesSteven gannonSherrington robinXenon pharmaceuticals price performanceCantor fitzgeraldIkarian capitalXenon pharmaceuticals incXenon pharmaceuticalsNeedham companySecurities exchange commissionRoyal bankInstitutional investors weigh in on xenon pharmaceuticalsNews ratings for xenon pharmaceuticals dailyVirtu financialArtal groupGet free report

Stock Traders Purchase Large Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE)

Stock Traders Purchase Large Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

New zealand generalNew zealandSteven gannonSherrington robinCapital international investorsNews ratings for xenon pharmaceuticals dailyWellington management groupRoyal bankAvoro capital advisorsSecurities exchange commissionXenon pharmaceuticals company profileXenon pharmaceuticalsNeedham companyXenon pharmaceuticals stock performanceXenon pharmaceuticals incCantor fitzgerald

Neurocrine, a regular name on Wall Street s M&A lists, elevates BD chief to succeed founder and CEO

Neurocrine, a regular name on Wall Street s M&A lists, elevates BD chief to succeed founder and CEO
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

United statesMichel vounatsosSosei heptaresNeurocrine biosciencesKyle ganoChris viehbacherNxera pharmaKevin gormanTanabe pharmaXenon pharmaceuticalsDiurnal groupNeurocrine biosciencesEffective octoberWall streetNorth americanMitsubishi tanabe pharma